Page 3 - Ben Brahim News Today

25.05.2022 - Regulatory News: The Combined Ordinary and Extraordinary General Meeting of Transgene’s (Paris:TNG) shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company’s headquarters (400 boulevard Gonthier d’Andernach – Parc d’Innovation – ... Seite 1

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces its business update for the quarter ended March 31, 2022. Over the first quarter of 2022, all of Transgene’s preclinical and clinical assets progressed in line with ...

The coronavirus pandemic forced many companies to halt business travel almost overnight. The economic consequences for airlines and hotels have been dramatic, leaving many wondering if corporate travel can bounce back.

The roles of Chairman and Chief Executive Officer will be separated. Dr. Riva proposed as new independent Director and non-executive Chairman of the Board. With more than 30 years of experience

TG4050 (myvac: First positive results from the two Phase I trials. Additional data to be presented at AACR 2022 in April. TG4001: First patient enrolled in Phase II study in June 2021. Active patient

Press release content from Business Wire. The AP news staff was not involved in its creation.

Regulatory News: Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today publishes its financial

Transgene Appoints Steven Bloom as Chief Business Officer - read this article along with other careers information, tips and advice on BioSpace

Transgene to receive $8 million upfront option exercise payment Conference call today on December 15, 2021, at 6:00 p.m. CET (12:00 p.m. ET) in English (details at the end of the release) Regulatory

Press release content from Business Wire. The AP news staff was not involved in its creation.